March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Outcomes following Boston Keratoprosthesis Type I Implantation in Aniridia Patients: The University of Montreal Experience
Author Affiliations & Notes
  • Salima I. Hassanaly
    University of Montreal, Montreal, Quebec, Canada
  • Julia Talajic
    University of Montreal, Montreal, Quebec, Canada
  • Mona Harissi-Dagher
    University of Montreal, Montreal, Quebec, Canada
  • Footnotes
    Commercial Relationships  Salima I. Hassanaly, None; Julia Talajic, None; Mona Harissi-Dagher, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 6066. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Salima I. Hassanaly, Julia Talajic, Mona Harissi-Dagher; Outcomes following Boston Keratoprosthesis Type I Implantation in Aniridia Patients: The University of Montreal Experience. Invest. Ophthalmol. Vis. Sci. 2012;53(14):6066.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To describe outcomes after Boston Keratoprosthesis Type 1 (KPro) surgery in aniridic eyes.

Methods: : A retrospective chart review of 21 aniridic eyes (15 patients) that underwent KPro implantation by a single surgeon (MHD) between October 2008 and April 2011 in a university center was performed. Preoperative and postoperative best-corrected visual acuity (BCVA), intraoperative and postoperative complications, and keratoprosthesis retention were examined.

Results: : Mean age was 54.3 years (range, 27-71); 8 patients were male. Six patients had bilateral procedures. No intraoperative complications were encountered. Preoperatively, BCVA was 20/200 or worse in all eyes. After a mean follow-up time of 20.9 months (range, 4.2-36.2), the most recent BCVA ranged from 20/70 to no light perception. Visual potential was limited by pre-existing terminal glaucoma (n=2), phthisis after retinal detachment (n=2), and suprachoroidal hemorrhage (n=2). Other postoperative complications included retroprosthetic membrane formation (n=11), trans-prosthetic leakage (n=2), and extrusion (n=1). Uncomplicated uveitis was reported in 6 eyes. No endophthalmitis or corneal melt occurred in this series. The majority of eyes have glaucoma and are on medical treatment.

Conclusions: : The prognosis in aniridic patients after KPro is variable, but is favorable overall. Meticulous follow-up and a subspecialty team approach are important.

Keywords: keratoprostheses 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×